Worldwide 3D Bioprinting Industry to 2027 – Featuring 3D Systems, Cellink and RegenHU Among Others – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “3D Bioprinting Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” report has been added to ResearchAndMarkets.com’s offering.

The global 3D bioprinting market reached a value of US$ 869.0 Million in 2021. Looking forward, the publisher expects the market to reach US$ 2,260.1 Million by 2027, exhibiting at a CAGR of 16.85% during 2022-2027.

Companies Mentioned

• 3D Systems Inc.
• Aspect Biosystems Ltd.
• Cellink
• Cyfuse Biomedical K.K.
• EnvisionTEC GmbH (Desktop Metal Inc.)
• GeSiM – Gesellschaft fur Silizium-Mikrosysteme mbH
• Materialise
• Organovo Holdings Inc.
• Poietis
• RegenHU
• Stratasys Ltd.

Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

3D bioprinting refers to an additive manufacturing technique used for the development of precise anatomical tissues through the decomposition of cell-based bio-inks. 3D bioprinting involves various deposition and assembling processes, such as direct and laser writing, microstamping, photolithography, stereolithography, electro-printing and inkjet deposition.

The bio-inks are manufactured using living cells, biomaterials and active biomolecules to create 3D structures of tissues and organs. The printer deposits multiple layers of biomaterials to build complex bodily structures, such as bones, skin, vascular grafts, tracheal splints, heart tissues and cartilages. These printed structures are assembled and bonded using dissolvable gel or collagen scaffolds to support and mold the cells in the desired shape.

The increasing prevalence of chronic respiratory and cardiovascular disorders (CVDs) across the globe is one of the key factors driving the growth of the market. Moreover, the rising requirement for regenerative medicines, cancer therapeutics and stem cell solutions is providing a thrust to the market growth. 3D bioprinting is widely used for liver modeling and development of various bone, tissue and medical implants. In line with this, the increasing consciousness among the masses to minimize animal testing is also contributing to the market growth. Cosmetic manufacturers use bio-printed hair follicles and skin grafts to clinically test the products on human-like tissues.

Additionally, various technological advancements, such as the development of organ-on-a-chip, are acting as other growth-inducing factors. These innovative bio-printed structures enable 3D in-vitro analysis of the bodily functions and fabrication of artificial organs and tissues for regenerative medicine and tissue engineering. Other factors, including extensive research and development (R&D) activities in the field of biotechnology, along with the increasing adoption of magnetic levitation technology for toxicity screening and vascular muscle printing, are anticipated to drive the market toward growth.

Key Questions Answered in This Report:

• How has the global 3D bioprinting market performed so far and how will it perform in the coming years?
• What has been the impact of COVID-19 on the global 3D bioprinting market?
• What are the key regional markets?
• What is the breakup of the market based on the component?
• What is the breakup of the market based on the application?
• What is the breakup of the market based on the end user?
• What are the various stages in the value chain of the industry?
• What are the key driving factors and challenges in the industry?
• What is the structure of the global 3D bioprinting market and who are the key players?
• What is the degree of competition in the industry?

Key Topics Covered:

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Introduction

4.1 Overview

4.2 Key Industry Trends

5 Global 3D Bioprinting Market

5.1 Market Overview

5.2 Market Performance

5.3 Impact of COVID-19

5.4 Market Forecast

6 Market Breakup by Component

7 Market Breakup by Application

8 Market Breakup by End User

9 Market Breakup by Region

10 SWOT Analysis

11 Value Chain Analysis

12 Porters Five Forces Analysis

13 Price Analysis

14 Competitive Landscape

14.1 Market Structure

14.2 Key Players

14.3 Profiles of Key Players

For more information about this report visit https://www.researchandmarkets.com/r/a5n9tt

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900